Boelaert, J.; Schepers, E.; Glorieux, G.; Eloot, S.; Vanholder, R.; Lynen, F.
Determination of Asymmetric and Symmetric Dimethylarginine in Serum from Patients with Chronic Kidney Disease: UPLC-MS/MS versus ELISA. Toxins 2016, 8, 149.
https://doi.org/10.3390/toxins8050149
AMA Style
Boelaert J, Schepers E, Glorieux G, Eloot S, Vanholder R, Lynen F.
Determination of Asymmetric and Symmetric Dimethylarginine in Serum from Patients with Chronic Kidney Disease: UPLC-MS/MS versus ELISA. Toxins. 2016; 8(5):149.
https://doi.org/10.3390/toxins8050149
Chicago/Turabian Style
Boelaert, Jente, Eva Schepers, Griet Glorieux, Sunny Eloot, Raymond Vanholder, and Frédéric Lynen.
2016. "Determination of Asymmetric and Symmetric Dimethylarginine in Serum from Patients with Chronic Kidney Disease: UPLC-MS/MS versus ELISA" Toxins 8, no. 5: 149.
https://doi.org/10.3390/toxins8050149
APA Style
Boelaert, J., Schepers, E., Glorieux, G., Eloot, S., Vanholder, R., & Lynen, F.
(2016). Determination of Asymmetric and Symmetric Dimethylarginine in Serum from Patients with Chronic Kidney Disease: UPLC-MS/MS versus ELISA. Toxins, 8(5), 149.
https://doi.org/10.3390/toxins8050149